Interventional Business Manager

Minimum of 10 years of progressive sales, marketing, or commercial leadership experience within medical devices, healthcare, biotechnology, or ophthalmology.

Demonstrated success leading field-based sales teams and achieving consistent revenue growth through effective coaching, talent development, and execution excellence.

Strong understanding of reimbursement processes, practice integration models, provider economics, and surgical sales environments.

Proven ability to influence cross-functional stakeholders, develop strategic business plans, and execute within complex matrix organizations.

Advanced communication, leadership, analytical, and business management skills with experience utilizing CRM platforms, Microsoft Excel, and PowerPoint. The scope and leadership expectations align with a senior commercial leadership role responsible for driving results through others and influencing regional business strategy.

Bachelor’s degree in Business, Marketing, Life Sciences, Healthcare Administration, or a related field required.

MBA or other advanced business or healthcare-related degree preferred

*Total Targeted Compensation $270K+ plus RSU's.

#GKOSUS #LI-remote

Founded in 1998, Glaukos Corporation is an ophthalmic pharmaceutical and medical technology company focused on developing and commercializing novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases.

Our mission at Glaukos is to truly transform vision by pioneering novel, dropless therapies that can meaningfully advance the standard of care and improve the lives of patients suffering from chronic, sight-threatening eye diseases.

Innovation is at the core of everything we do, and we are resolute in our commitment to challenge conventional thinking with new treatment alternatives that are supported by real science, robust clinical evidence, and an unrelenting focus on patients.

Our constant pursuit of game-changing technologies that disrupt legacy treatment paradigms is encapsulated in the Glaukos mantra “We’ll Go First,” which articulates our willingness to take chances, our determination to forge new ground, and our commitment to continuous improvement in all that we do.

Our company completed an initial public offering in June of 2015, and our shares are traded on the New York Stock Exchange under the ticker symbol “GKOS”. Our global headquarters is in Aliso Viejo, California with additional locations in San Clemente, California, and Burlington, Massachusetts.

Glaukos Corporation is an Equal Opportunity/Affirmative Action Employer . All qualified applicants will receive consideration for employment without regard to race, color, religion, sex including sexual orientation and gender identity, national origin, disability, protected Veteran Status, or any other characteristic protected by applicable federal, state, or local law.

All offers of employment are contingent upon the successful completion of a background check, including successfully passing a drug screen, based on the position and local regulations.